
More Than a Million Americans Removed From Health Care Plan in One Month
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
More than one million Americans lost health coverage in a single month at the end of last year as states continued to unwind pandemic-era coverage protections.
According to data published by KFF, a nonprofit health policy research and news organization, national enrollment in Medicaid and the Children's Health Insurance Program (CHIP) dropped from 79,569,888 in November 2024 to 78,532,341 in December 2024, a net loss of 1,037,547 enrollees.
Newsweek has contacted the Centers for Medicare & Medicaid Services (CMS) outside of regular hours via email for comment.
Why It Matters
The unwinding process has significantly reshaped Medicaid enrollment across the U.S. Under federal rules in place during the pandemic, states were required to keep most Medicaid recipients continuously enrolled, even if their eligibility status changed. That requirement expired in March 2023, allowing states to resume removing individuals from the program.
Since the unwinding began, enrollment has steadily declined, driven by both eligibility losses and procedural disenrollments—when individuals lose coverage due to missing paperwork or administrative errors rather than no longer qualifying.
File photo: Medicaid activists wait to enter the House Energy and Commerce.
File photo: Medicaid activists wait to enter the House Energy and Commerce.
Tom Williams/CQ Roll Call via AP
What To Know
The drop represents one of the many steep single-month declines recorded since states began redetermining eligibility in early 2023, following the end of the COVID-19 public health emergency declaration.
The December enrollment figure of 78.5 million is the lowest recorded figure since late 2020. For comparison, total Medicaid enrollment peaked at 94.6 million in April 2023, during the pandemic-era continuous coverage period.
State-by-state trends also show uneven disenrollment rates, with Utah reporting disenrollment rates as high as 31 percent between March 2023 and December 2024, followed by Texas with 30 percent, while South Dakota saw a 2 percent decrease in enrollment in the same time frame.
California, Maine, Alaska, Connecticut, and Oregon were other states that only saw a single-figure disenrollment rate during that time.
KFF reported that child enrollment in the two programs is now below pre-pandemic enrollment in 13 states, while adult enrollment is below pre-pandemic levels in 7 states.
Although, while in some states' disenrollment happened rapidly, returning to enrollment rates matching the early 2020 numbers, national Medicaid and CHIP enrollment is not yet back to pre-pandemic levels.
What People Are Saying
Eileen Sullivan-Marx, dean and professor of New York University Rory Meyers College of Nursing, told Newsweek: "It would be hard to know what caused this one month decline, however, it does reinforce that there is a projected trend downward continuing. It could be that some of the state differentials that month are skewing the whole data downward between November and December. I also notice that this is mostly a steeper downward trend for adults. The tendencies presently occurring have to do with disenrollments and the difficulty to re-enroll once disenrolled. If states do not make sure that there is a smooth way to re-enroll or enroll on a regular basis then there could be sharper decline in those enrolled in Medicaid."
She added: "Disenrollments that are occurring simply because it is hard to re-enroll have consequences for those who need coverage in terms of accessing health care, getting medications, having to pay privately for a nursing home stay."
Ben Anderson, the deputy senior director of health policy at Families USA, a health care-focused consumer advocacy group, told KFF in September: "We have seen some amazing coverage expansion in places like Oregon and California. But if you live in Texas, Florida, and Georgia, since the pandemic your health coverage has been disrupted in ways that were preventable by state leaders."
What Happens Next
As the unwinding continues, more reductions in enrollment are expected. With millions already having lost health coverage, concerns remain about access to care for low-income individuals and families.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
an hour ago
- Business Insider
Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19
Moderna (MRNA) announced that the U.S. Food and Drug Administration, FDA, has approved mNEXSPIKE, a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention. 'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,' said Stephane Bancel, Chief Executive Officer of Moderna. 'COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health.' Confident Investing Starts Here:


CNBC
5 hours ago
- CNBC
FDA approves Moderna's new lower-dose Covid-19 vaccine
The U.S. approved a new Covid-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current Covid-19 vaccine, Spikevax — by refining its immune target. The approval "adds an important new tool to help protect people at high risk of severe disease from Covid-19," Stephane Bancel, Moderna's CEO, said in a statement Saturday. The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus. That's the same limit that the FDA set in licensing another Covid-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled Covid-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials. Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall. The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said. The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results.
Yahoo
7 hours ago
- Yahoo
‘Absolute Disaster:' Senate Dems Take Aim At Trump's Tax Bill
Senate Democrats laid into President Donald Trump's sweeping tax bill on Sunday, emphasizing the impact it is poised to make on millions of Americans on Medicaid. 'This Republican budget bill is an absolute disaster for the country, in particular for middle-class and poor people,' Sen. Chris Murphy (D-CT) said in an interview on CNN's State of the Union, noting that it seeks to pay for tax cuts by curbing spending on social programs. Sen. Raphael Warnock (D-GA) echoed these concerns in an interview on NBC News's Meet the Press, stressing that 'Republicans are trying to push forward this big ugly bill that's going to literally cut as many as seven million Americans off of their healthcare.' Murphy and Warnock's statements come as Republicans' massive tax and spending bill heads to the Senate, where it's likely to face staunch Democratic opposition as well as GOP dissent. The bill slashes spending on social programs like SNAP and Medicaid, while proposing trillions in tax cuts and billions in investments to strengthen border security. According to an initial analysis from the nonpartisan Congressional Budget Office, it would push 7.6 million people off Medicaid, in part by making it more difficult to qualify for the program. One way it does so is by imposing a new work requirement, which would force many able-bodied recipients to prove that they've worked, volunteered or attended a training program to obtain Medicaid coverage. Warnock stressed that a similar policy in Georgia has added new barriers for people in need of healthcare. This 'work reporting requirement is very good at kicking people off of their health care,' he said. 'It's not very good at incentivizing work at all.' Earlier this May, House Republicans narrowly passed the bill by just one vote. It'll take a simple majority – which Republicans have – to advance again in the Senate, though some GOP lawmakers have said they'd like to make changes of their own to tax and Medicaid provisions. GOP Senators like Rick Scott (R-FL) have also raised concerns about how the bill could add to the federal debt, an issue Murphy alluded to as well on Sunday. 'It's just unreal the amount of gaslighting this administration is doing,' Murphy said, while referring to the White House's claims that the legislation won't alter the deficit at all.